ticker
stringlengths 1
5
| name
stringlengths 2
91
| sector
stringclasses 13
values | industry
stringclasses 143
values | country
stringclasses 49
values | market_cap
stringlengths 3
13
| currency
stringclasses 2
values | employees
stringlengths 1
7
| description
stringlengths 3
5.34k
|
|---|---|---|---|---|---|---|---|---|
ERX
|
Direxion Daily Energy Bull 2X Shares
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The index is provided by S&P Dow Jones Indices and includes domestic companies from the energy sector which includes the following industries: oil, gas and consumable fuels; and energy equipment and services. The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 2X daily leveraged exposure to the index, consistent with the fund's investment objective. It is non-diversified.
|
MITK
|
Mitek Systems, Inc.
|
Technology
|
Software - Application
|
United States
|
376427584
|
USD
|
565
|
Mitek Systems, Inc. provides mobile image capture and digital identity verification solutions worldwide. Its product portfolio includes Mobile Deposit that enables individuals and businesses to remotely deposit checks using their camera-equipped smartphone or tablet; and Mobile Verify, an identity verification solution that is integrated into mobile apps, mobile websites, and desktop applications. The company also offers MiSnap, a mobile-capture software development kit that enables an intuitive user experience and instant capture of quality images of identity documents and checks. CheckReader enables financial institutions to automatically extract data from checks once they have been scanned or photographed by the application; Check Fraud Defender, an AI-powered and cloud-hosted consortium designed to combat check fraud; and Check Intelligence that enables financial institutions to automatically extract data from a check image received across any deposit channel, including branch, ATM, remote deposit capture, and mobile. In addition, it provides MiVIP, an end-to-end identity verification solution designed for KYC process; and MiPass, an authentication solution, including facial and voice biometrics to safeguard against sophisticated fraud techniques. Further, the company provides IDLive Face, a passive facial liveness detection product; IDVoice, a robust AI-driven voice biometric engine; IDLive Voice to stop spoofing attacks on voice biometric systems; and IDLive Doc that works to fight fraud related to digitally displayed document images. The company was incorporated in 1986 and is based in San Diego, California.
|
REZI
|
Resideo Technologies, Inc.
|
Industrials
|
Industrial Distribution
|
United States
|
2414512384
|
USD
|
14600
|
Resideo Technologies, Inc. develops, manufactures, sells, and distributes comfort, energy management, and safety and security solutions in the United States, Europe, and internationally. The company operates in two segments, Products and Solutions, and ADI Global Distribution. The Products and Solutions segment offers temperature and humidity control, water and air solutions, smoke and carbon monoxide detection home safety products, residential and small business security products, video cameras, other home-related lifestyle convenience solutions, cloud infrastructure, installation and maintenance tools, and related software products under the Honeywell Home, First Alert, Resideo, Braukmann, and BRK brand names. The ADI Global Distribution segment distributes low-voltage products, including security, fire, and access control; and participates in the broader related markets of smart home, residential audio-visual, professional audio-visual, power management, networking, data communications, wire and cable, enterprise connectivity, and structured wiring products. The company sells its products and services through a network of professional contractors, installers and integrators, distributors, and original equipment manufacturers, as well as retailers and online merchants. Resideo Technologies, Inc. was incorporated in 2018 and is headquartered in Scottsdale, Arizona.
|
EQ
|
Equillium, Inc.
|
Healthcare
|
Biotechnology
|
United States
|
16786172
|
USD
|
35
|
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States. Its lead product candidate is Itolizumab (EQ001), a first-in-class anti-CD6 immune-modifying monoclonal antibody, which is in phase 3 clinical trial to treat acute graft-versus-host disease, as well as completed Phase 1b clinical trial to treat systemic lupus erythematosus and lupus nephritis and in phase 2 clinical trial for the treatment of ulcerative colitis. The company also develops EQ101, first-in-class, selective, tri-specific inhibitor of IL-2, IL-9 and IL-15, which completed Phase 1/2 to treat cutaneous T cell lymphoma. It serves its products to gastroenterology, dermatology, hematology, transplant science, rheumatology, pulmonology, and oncology areas. The company has a collaboration and license agreement with Biocon SA to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise exploit itolizumab (EQ001) and any pharmaceutical composition or preparation containing or comprising itolizumab (EQ001) that uses Biocon technology or Biocon know-how, or collectively, a Biocon Product. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
|
OUSA
|
ALPS O'Shares U.S. Quality Dividend ETF Shares
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The underlying index is designed to measure the performance of publicly listed large-capitalization and mid-capitalization dividend-paying issuers in the United States that meet certain market capitalization, liquidity, high quality, low volatility and dividend yield thresholds, as determined by O'Shares Investment Advisers, LLC (the "index provider"). Under normal market conditions, the fund will invest at least 80% of its total assets in the components of the underlying index.
|
ATEX
|
Anterix Inc.
|
Communication Services
|
Telecom Services
|
United States
|
559834496
|
USD
|
86
|
Anterix Inc. operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and broadband solutions. It offers CatalyX, a turnkey connectivity management solution platform. The company also holds licensed spectrum in the 900 MHz band with coverage throughout the United States. The company was formerly known as pdvWireless, Inc. and changed its name to Anterix Inc. in August 2019. Anterix Inc. was incorporated in 1997 and is headquartered in Woodland Park, New Jersey.
|
PMX
|
PIMCO Municipal Income Fund III
|
Financial Services
|
Asset Management
|
United States
|
228702240
|
USD
|
N/A
|
PIMCO Municipal Income Fund III is a closed-ended fixed income mutual fund launched and managed by Pacific Investment Management Company LLC. The fund invests in fixed income markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in in municipal bonds that pay interest that is exempt from federal income tax. PIMCO Municipal Income Fund III was formed on October 31, 2002 and is domiciled in United States.
|
SWTX
|
SpringWorks Therapeutics, Inc.
|
Healthcare
|
Biotechnology
|
United States
|
3369048320
|
USD
|
368
|
SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. It offers OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor for the treatment of desmoid tumors; and GOMEKLI (mirdametinib), an oral small molecule inhibitor of MEK1 and MEK2 for the treatment of adult and pediatric patients two years of age and older with neurofibromatosis type 1-associated plexiform neurofibromas (NF1-PN). The company also develops Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer; and mirdametinib for the treatment of solid tumors harboring other MAPK aberrations, including for the treatment of pediatric and young adult patients with low-grade gliomas that is in Phase 1/2 clinical trial. In addition, its products under development include Brimarafenib (BGB-3245), an oral selective small molecule inhibitor of monomeric and dimeric forms of activating BRAF mutations. The company has license agreements with Pfizer Inc. for nirogacestat and mirdametinib; and Katholieke Universiteit Leuven and the Flanders Institute for Biotechnology for a portfolio of novel small molecule inhibitors of the TEA Domain. SpringWorks Therapeutics, Inc. was founded in 2017 and is headquartered in Stamford, Connecticut.
|
SVXY
|
ProShares Short VIX Short-Term Futures ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The index seeks to offer exposure to market volatility through publicly traded futures markets and is designed to measure the implied volatility of the S&P 500 over 30 days in the future.
|
MHI
|
Pioneer Municipal High Income Fund, Inc.
|
Financial Services
|
Asset Management
|
United States
|
205397136
|
USD
|
N/A
|
Pioneer Municipal High Income Fund, Inc. is a closed-ended fixed income mutual fund launched and managed by Pioneer Investment Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in municipal securities. It seeks to invest in securities across the credit rating and maturity spectrum. The fund benchmarks the performance of its portfolio against the Barclays Municipal Bond Index and Barclays High Yield Municipal Bond Index. Pioneer Municipal High Income Fund, Inc. was formed on March 13, 2003 and is domiciled in the United States.
|
RNA
|
Avidity Biosciences, Inc.
|
Healthcare
|
Biotechnology
|
United States
|
3718162944
|
USD
|
391
|
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's product candidate Delpacibart etedesiran is for the treatment of myotonic dystrophy type 1 and is currently in phase 3 trial. Its other products in pipeline include Delpacibart zotadirsen for the treatment of duchenne muscular dystrophy, which is under phase 2 clinical development trial; and Delpacibart braxlosiran for the treatment of facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare genetic cardiomyopathies for PRKAG2 syndrome and PLN cardiomyopathy. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.
|
BSL
|
Blackstone Senior Floating Rate 2027 Term Fund
|
Financial Services
|
Asset Management
|
United States
|
182410016
|
USD
|
N/A
|
Blackstone Senior Floating Rate 2027 Term Fund is a closed-ended fixed income mutual fund launched by The Blackstone Group L.P. It is managed by GSO / Blackstone Debt Funds Management LLC. The fund invests in the fixed income markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in senior secured, floating rate loans that are issued by corporations, partnerships, and other business entities. It seeks to invest in securities that are rated below investment grade. The fund invests in securities across the maturity spectrum, while maintaining an average duration of less than one year. It employs fundamental analysis using a research-driven credit analysis approach while focusing on factors like companies which offer attractive risk / return characteristics to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index. Blackstone Senior Floating Rate 2027 Term Fund was formed on March 4, 2010 and is domiciled in the United States.
|
RDFN
|
Redfin Corporation
|
Real Estate
|
Real Estate Services
|
United States
|
1169096576
|
USD
|
4778
|
Redfin Corporation operates as a residential real estate brokerage company in the United States and Canada. The company operates an online real estate marketplace and provides real estate services, including assisting individuals in the purchase or sell of home. It also provides title and settlement services; and originates, sells, and services mortgages. In addition, the company uses digital platforms to connect consumers with rental properties and for other advertising. The company was formerly known as Appliance Computing Inc. and changed its name to Redfin Corporation in May 2006. Redfin Corporation was incorporated in 2002 and is headquartered in Seattle, Washington.
|
QQQX
|
Nuveen Nasdaq 100 Dynamic Overwrite Fund
|
Financial Services
|
Asset Management
|
United States
|
1151824256
|
USD
|
N/A
|
Nuveen Nasdaq 100 Dynamic Overwrite Fund is a closed-ended equity indexed mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Asset Management, LLC and Nuveen Fund Advisors LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in the stocks of large-cap companies. The fund also invests through index call options. It seeks to replicate the performance of its portfolio against the NASDAQ 100 Index. The fund was previously known as NASDAQ Premium Income & Growth Fund Inc. Nuveen Nasdaq 100 Dynamic Overwrite Fund was formed on January 30, 2007 and is domiciled in the United States.
|
DFE
|
WisdomTree Europe SmallCap Dividend Fund
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
Under normal circumstances, at least 95% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in constituent securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such constituent securities. The index is a fundamentally weighted index that is comprised of the small-capitalization segment of the European dividend-paying market. The fund is non-diversified.
|
CHW
|
Calamos Global Dynamic Income Fund
|
Financial Services
|
Asset Management
|
United States
|
406177600
|
USD
|
N/A
|
Calamos Global Dynamic Income Fund is a closed ended balanced mutual fund launched by Calamos Investments LLC. The fund is managed by Calamos Advisors LLC. It invests in public equity and fixed income markets across the globe. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in growth stocks of companies across all market capitalizations, as well as in higher yield corporate bonds, government bonds, convertibles, and alternative investments such as arbitrage and call writes. The fund employs both fundamental and quantitative analysis, focusing on such factors as source, sustainability, and risk of investment opportunities to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Index and Merrill Lynch Global Broad Markets Index. The fund was formerly known as Calamos Global Diversified Income & Opportunities Fund. Calamos Global Dynamic Income Fund was formed on April 10, 2007 and is domiciled in the United States.
|
HARP
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
USIG
|
iShares Broad USD Investment Grade Corporate Bond ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund will invest at least 80% of its assets in the component securities of the underlying index, and the fund will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index measures the performance of investment-grade corporate bonds of both U.S. and non-U.S. issuers that are U.S. dollar-denominated and publicly issued in the U.S. domestic market.
|
AMPE
|
Ampio Pharmaceuticals, Inc.
|
Healthcare
|
Biotechnology
|
United States
|
24694
|
USD
|
6
|
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
|
EFOI
|
Energy Focus, Inc.
|
Consumer Cyclical
|
Furnishings, Fixtures & Appliances
|
United States
|
9732378
|
USD
|
9
|
Energy Focus, Inc., together with its subsidiaries, designs, develops, manufactures, markets, and sells energy-efficient lighting systems and controls in the United States and internationally. It offers military maritime markets light-emitting diode (LED) lighting products, such as Intellitube and Invisitube retrofit LEDs; and military-grade LED fixtures comprising globe lights, berth lights, and high-bay kits to serve the United States navy and allied foreign navies. The company also provides energy-saving GaN power supplies for efficient power delivery; and energy storage systems (ESS) and uninterruptible power supply (UPS) products designed for AI data centers. In addition, it offers commercial products, including RedCap emergency backup LED tubes; LED retrofit kits for replacing fluorescent lamps, downlights, and low/high-bay fixtures; and industrial LED dock lights. The company sells its products to commercial, industrial, and military markets through direct sales employees, lighting agents, independent sales representatives, and distributors, as well as via e-commerce channels. The company was formerly known as Fiberstars, Inc. and changed its name to Energy Focus, Inc. in May 2007. Energy Focus, Inc. was founded in 1985 and is based in Solon, Ohio.
|
FHLC
|
Fidelity MSCI Health Care Index ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.
|
HIX
|
Western Asset High Income Fund II Inc.
|
Financial Services
|
Asset Management
|
United States
|
369143488
|
USD
|
N/A
|
Western Asset High Income Fund II Inc. is a closed-ended fixed income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. The fund is co-managed by Western Asset Management Company, Western Asset Management Company Limited, and Western Asset Management Company Pte. Ltd. It invests in the fixed income markets across the globe. The fund invests in securities of companies that operate across diversified sectors. It invests in high yield debt securities issued by U.S., foreign corporations and foreign governments. The fund employs a combination of quantitative and fundamental analysis with bottom-up security selection process to create its portfolio. It benchmarks the performance of its portfolio against Barclays Capital U.S. Corporate High Yield 2% Issuer Cap Index and the JPMorgan Emerging Markets Bond Index Global. Western Asset High Income Fund II, Inc. was formed on May 28, 1998 and is domiciled in the United States.
|
SUSL
|
iShares ESG MSCI USA Leaders ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund generally will invest at least 90% of its assets in the component securities of the underlying index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The underlying index is a free float-adjusted market capitalization-weighted index designed to reflect the equity performance of U.S. companies that have favorable environmental, social and governance (“ESG”) characteristics. It is non-diversified.
|
PHYS
|
Sprott Physical Gold Trust
|
N/A
|
N/A
|
N/A
|
22190045184
|
USD
|
N/A
|
N/A
|
FIF
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
XBIT
|
XBiotech Inc.
|
Healthcare
|
Biotechnology
|
United States
|
90243760
|
USD
|
92
|
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
|
ETW
|
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
|
Financial Services
|
Asset Management
|
United States
|
873127936
|
USD
|
N/A
|
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. It is co-managed by Parametric Portfolio Associates LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating across diversified sectors. The fund also writes call options on one or more U.S. and foreign indices on a substantial portion of the value of its common stock portfolio. It benchmarks the performance of its portfolio against the S&P 500 Index, the CBOE S&P 500 BuyWrite Index, the CBOE NASDAQ-100 BuyWrite Index, and the FTSE Eurotop 100 Index. Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund was formed on September 30, 2005 and is domiciled in the United States.
|
DDM
|
ProShares Ultra Dow30
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The index is designed to measure the performance of some of the largest U.S. companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified.
|
DPST
|
Direxion Daily Regional Banks Bull 3X Shares
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS regional banks sub-industry. The fund is non-diversified.
|
DMRC
|
Digimarc Corporation
|
Technology
|
Information Technology Services
|
United States
|
285404224
|
USD
|
215
|
Digimarc Corporation, together with its subsidiaries, provides digital watermarking solutions in the United States and internationally. The company offers Digimarc Illuminate software as a service cloud-based platform that provides the tools for the application of advanced digital watermarks and dynamic quick response codes; software that enables various systems and devices to interact with data carriers; and a platform to capture insights about digital interactions and automating activities. It also provides Digimarc Automate, an automated product inspection solution for accuracy and efficiency in production, fulfillment, and distribution facilities; Digimarc Engage, consumer engagement solution activates products and multimedia to create and leverage an interactive communications channel; Digimarc Recycle sortation software; Digimarc Retail Experience for retail checkout systems; and Digimarc Validate supports authentication to help ensure online interactions can be trusted and that real products and digital assets are genuine. The company offers its solutions to retailers, consumer brands, their suppliers and related solution providers, as well as media, entertainment, and other customers; and central banks and other government customers through its sales personnel and business partners. Digimarc Corporation was incorporated in 2008 and is based in Beaverton, Oregon.
|
DRV
|
Direxion Daily Real Estate Bear 3X Shares
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund invests at least 80% of the fund’s net assets in financial instruments, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is provided by S&P Dow Jones Indices and includes securities of companies from the following industries: real estate management and development and REITs, excluding mortgage REITs. The fund is non-diversified.
|
CDTX
|
Cidara Therapeutics, Inc.
|
Healthcare
|
Biotechnology
|
United States
|
235938400
|
USD
|
38
|
Cidara Therapeutics, Inc. operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company's product includes rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also develops its Cloudbreak platform that enables development of novel drug-Fc conjugates, that includes CD388, a potent antiviral designed to deliver universal prevention and treatment of seasonal and pandemic influenza, which is in Phase 1 and Phase 2a clinical trials. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.
|
SPXU
|
ProShares UltraPro Short S&P500
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is designed to measure the performance of the 500 largest companies listed and domiciled in the U.S. The fund is non-diversified.
|
GNT
|
GAMCO Natural Resources, Gold & Income Trust
|
Financial Services
|
Asset Management
|
United States
|
96864176
|
USD
|
N/A
|
GAMCO Natural Resources, Gold & Income Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in public equity markets across the globe. The fund invests in securities of companies principally engaged in natural resource and gold industries and by writing covered call options on the underlying equity securities. It focuses on factors such as recent prices of comparable securities that are publicly traded, reliable prices of securities not publicly traded, the use of valuation models, current analyst reports, valuing the income or cash flow of the issuer, or cost if the preceding factors do not apply to create its portfolio. The fund invests in stocks of companies across market capitalization. It benchmarks the performance of its portfolio against the CBOE S&P 500 Buy/Write Index, Philadelphia Gold & Silver Index, Dow Jones U.S. Basic Materials Index, and S&P Global Agribusiness Equity Index. The fund was formerly known as Gabelli Natural Resources, Gold & Income Trust. GAMCO Natural Resources, Gold & Income Trust was formed on January 27, 2011 and is domiciled in the United States.
|
CAF
|
Morgan Stanley China A Share Fund, Inc.
|
Financial Services
|
Asset Management
|
United States
|
219513760
|
USD
|
N/A
|
Morgan Stanley China A Share Fund, Inc. is a closed ended equity mutual fund launched and managed by Morgan Stanley Investment Management Inc. It is co-managed by Morgan Stanley Investment Management Company. The fund invests in the public equity markets of China. It seeks to invest in the stocks of companies operating across diversified sectors. The fund invests in the growth stocks of companies. It employs fundamental analysis with bottom-up stock picking approach to create its portfolio. The fund benchmarks the performance of its portfolio against the Morgan Stanley Capital International China A Share Index. Morgan Stanley China A Share Fund, Inc. was formed on July 6, 2006 and is domiciled in the United States.
|
HUSV
|
First Trust Horizon Managed Volatility Domestic ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund seeks to achieve its investment objective by investing at least 80% of its net assets in common stocks of domestic companies listed and traded on U.S. national securities exchanges that the sub-advisor believes exhibit low future expected volatility. To implement this strategy, the sub-advisor employs volatility forecasting models to forecast future expected volatility. The strategy is largely quantitative and rules-based, but also includes multiple parameters over which the sub-advisor may exercise discretion in connection with its active management of the fund.
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
Healthcare
|
Biotechnology
|
United States
|
3126276352
|
USD
|
437
|
Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company's lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist, which is in a Phase 3 clinical trial for the treatment of acromegaly and carcinoid syndrome associated with neuroendocrine tumors. It is also developing Atumelnant, an investigational oral nonpeptide product candidate to antagonize the adrenocorticotrophic hormone (ACTH) receptor that has completed a Phase 1 study for the treatment of diseases caused by excess ACTH, including congenital adrenal hyperplasia and cushing's disease; and CRN09682, a nonpeptide drug conjugate for SST2 positive solid tumors. In addition, the company is developing antagonists of the parathyroid hormone (PTH) receptor for the treatment of primary hyperparathyroidism and humoral hypercalcemia of malignancy, and other diseases of excess PTH; thyroid-stimulating hormone receptor antagonists for the treatment of graves' disease and thyroid eye disease; SST3 Agonist program for the treatment for autosomal dominant polycystic kidney disease; and Radionetics for multiple solid-tumors, as well as Oral GLP-1 and Oral GIP nonpeptides for the treatment of obesity. The company has an agreement with Sanwa Kagaku Kenkyusho Co., Ltd to develop and commercialize Paltusotine in Japan, and Cellular Longevity, Inc. to develop and commercialize CRN01941, a somatostatin receptor type 2 agonist. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
|
GLQ
|
Clough Global Equity Fund
|
Financial Services
|
Asset Management
|
United States
|
116521000
|
USD
|
N/A
|
Clough Global Equity Fund is a closed ended equity mutual fund launched and managed by Clough Capital Partners, L.P. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across diversified sectors. It employs fundamental and quantitative analysis with a bottom up stock picking approach to create its portfolio, with focus on factors such as a company's competitive position, quality of company management, quality and visibility of earnings and cash flow, balance sheet strength, and relative valuation. The fund follows a theme-based investment process which involves focusing on such events as industry consolidation, technological change, an emerging shortage of a product or raw material, and changes in government regulations. It benchmarks the performance of its portfolio against the S&P 500 Index. Clough Global Equity Fund was formed on January 25, 2005 and is domiciled in the United States.
|
BWFG
|
Bankwell Financial Group, Inc.
|
Financial Services
|
Banks - Regional
|
United States
|
253915024
|
USD
|
145
|
Bankwell Financial Group, Inc. operates as the bank holding company for Bankwell Bank that provides various banking services for individual and commercial customers. It offers various traditional depository products, including checking, savings, money market, and certificates of deposit. The company also provides first mortgage loans secured by one-to-four family owner occupied residential properties for personal use; home equity loans and home equity lines of credit secured by owner occupied one-to-four family residential properties; loans secured by commercial real estate, multi-family dwellings, owner-occupied commercial real estate, and investor-owned one-to-four family dwellings; commercial construction loans for commercial development projects, including apartment buildings and condominiums, as well as office buildings, retail, and other income producing properties; land loans; commercial business loans secured by assignments of corporate assets and personal guarantees of the business owners; loans to finance insurance premiums; overdraft lines of credit; and personal loans. It operates branches in New Canaan, Stamford, Fairfield, Westport, Darien, Norwalk, and Hamden, Connecticut. The company was formerly known as BNC Financial Group, Inc. and changed its name to Bankwell Financial Group, Inc. in September 2013. Bankwell Financial Group, Inc. was founded in 2002 and is headquartered in New Canaan, Connecticut.
|
CRF
|
Cornerstone Total Return Fund, Inc.
|
Financial Services
|
Asset Management
|
United States
|
811245696
|
USD
|
N/A
|
Cornerstone Total Return Fund, Inc. is a closed-ended equity mutual fund launched and managed by Cornerstone Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in value and growth stocks of companies across all market capitalizations. The fund also invests through other closed-end investment companies and ETFs. It benchmarks the performance of its portfolio against the S&P 500 Index. Cornerstone Total Return Fund, Inc. was formed on March 16, 1973 and is domiciled in the United States.
|
VXX
|
iPath Series B S&P 500 VIX Short-Term Futures ETN
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The ETN offers exposure to futures contracts of specified maturities on the VIX index and not direct exposure to the VIX index or its spot level. The index is designed to provide investors with exposure to one or more maturities of futures contracts on the CBOE Volatility Index®.
|
RWX
|
SPDR Dow Jones International Real Estate ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in depositary receipts based on securities comprising the index. The index is a float-adjusted market capitalization index designed to measure the performance of publicly traded real estate securities in countries excluding the United States.
|
CYCC
|
Cyclacel Pharmaceuticals, Inc.
|
Healthcare
|
Biotechnology
|
Malaysia
|
57743076
|
USD
|
N/A
|
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
|
RNP
|
Cohen & Steers REIT and Preferred Income Fund, Inc.
|
Financial Services
|
Asset Management
|
United States
|
1005337216
|
USD
|
N/A
|
Cohen & Steers REIT and Preferred Income Fund, Inc. is a closed-ended balanced mutual fund launched by Cohen & Steers Inc. It is managed by Cohen & Steers Capital Management, Inc. The fund invests in the public equity and fixed income markets of the United States. It seeks to invest in the stocks of companies operating in the real estate sector including real estate investment trusts. For its fixed income portfolio, the fund typically invests in debt and preferred securities of companies operating across diversified sectors. It employs fundamental analysis to create its fixed income portfolio with a focus on the issuer's creditworthiness, corporate and capital structure, placement of the preferred or debt securities within that structure, momentum and other exogenous signals, and relative value versus other income security classes and for its equity portfolio also it employs fundamental analysis to create its portfolio with a focus on growth potential, earnings estimates, and the quality of management. The fund benchmarks the performance of its portfolio against the FTSE NAREIT Equity Index, S&P 500 Index, Merrill Lynch Fixed Rate Preferred Index, and FTSE NAREIT Equity REIT Index. It was formerly known as Cohen & Steers REIT & Preferred Balanced Income Fund. Cohen & Steers REIT and Preferred Income Fund, Inc. was formed on June 27, 2003 and is domiciled in the United States.
|
KNSA
|
Kiniksa Pharmaceuticals International, plc
|
Healthcare
|
Drug Manufacturers - Specialty & Generic
|
United Kingdom
|
1499842176
|
USD
|
315
|
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition; and KPL-387, an investigational, that is in Phase 2/3 clinical trial for human immunoglobulin G2 monoclonal antibody that binds human interleukin-1 receptor 1, inhibiting IL-1a, IL-1ß-mediated signaling for the treatment of advance recurrent pericarditis by providing the added convenience of monthly subcutaneous dosing with a liquid formulation. Its preclinical products include KPL-116, a Fc-modified immunoglobulin G2 monoclonal antibody. The company was formerly known as Kiniksa Pharmaceuticals, Ltd and changed its name tpKiniksa Pharmaceuticals International, plc in June 2024. The company was incorporated in 2015 and is based in London, the United Kingdom.
|
KE
|
Kimball Electronics, Inc.
|
Industrials
|
Electrical Equipment & Parts
|
United States
|
357761984
|
USD
|
7000
|
Kimball Electronics, Inc. engages in the provision of electronics manufacturing, engineering, and supply chain support services to customers in the automotive, medical, and industrial end markets. The Company also offers contract manufacturing services, including engineering and supply chain support for the production of electronic assemblies and other products, including non-electronic components, medical devices, medical disposables, and precision molded plastics, as well as automation, test, and inspection equipment primarily used in automotive, medical, and industrial applications. In addition, it is also involved in the production and testing of printed circuit board assemblies, as well as clean room assembly, cold chain, and product sterilization management activities. Further, the company offers design services and support, supply chain services and support, rapid prototyping and new product introduction support, product design and process validation and qualification, industrialization and automation of manufacturing processes, reliability testing, aftermarket services, drug delivery devices and solutions with and without electronics, and product life cycle management services, as well as and assembly of medical, automotive, and industrial products. It operates in the United States, China, Mexico, Poland, Romania, Thailand, India, Japan, Vietnam, and internationally. Kimball Electronics, Inc. was founded in 1961 and is headquartered in Jasper, Indiana.
|
CWBC
|
Community West Bancshares
|
Financial Services
|
Banks - Regional
|
United States
|
331280672
|
USD
|
346
|
Community West Bancshares operates as the bank holding company for the Central Valley Community Bank that provides various commercial banking services to small and middle-market businesses and individuals in California. The company accepts demand, savings, and time deposits; certificates of deposit; and non-interest-bearing demand deposits, as well as provides NOW and money market accounts. It also provides products, such as commercial and industrial loans, as well as loans secured by crop production and livestock; commercial real estate construction and other land loans, real estate collateral secured by commercial or professional properties with repayment arising from the owner's business cash flows, investor commercial real estate loans, farmland, and multi-family loans; 1-4 family close-ended, revolving real estate loans, and residential construction loans; manufactured housing loans; and equity loans, lines of credit, and installment and other consumer loans. In addition, the company offers domestic and international wire transfer, inquiry, account status, bill paying, account transfers, cash management, and other customary banking services. The company was formerly known as Central Valley Community Bancorp and changed its name to Community West Bancshares in April 2024. Community West Bancshares was founded in 1979 and is based in Fresno, California.
|
INDO
|
Indonesia Energy Corporation Limited
|
Energy
|
Oil & Gas E&P
|
Indonesia
|
31689164
|
USD
|
33
|
Indonesia Energy Corporation Limited, together with its subsidiaries, operates as an oil and gas exploration and production company in Indonesia. It holds interests in the Kruh Block, a producing block covering approximately an area of 258 square kilometers located in the Pali, South Sumatra; and the Citarum Block, an exploration block covering approximately an area of 3,924.67 square kilometers located in the onshore of West Java. The company was incorporated in 2018 and is headquartered in Jakarta, Indonesia. Indonesia Energy Corporation Limited is a subsidiary of Maderic Holding Limited.
|
NKSH
|
National Bankshares, Inc.
|
Financial Services
|
Banks - Regional
|
United States
|
165956672
|
USD
|
245
|
National Bankshares, Inc. operates as the bank holding company for the National Bank of Blacksburg that provides retail and commercial banking products and services to individuals, businesses, non-profits, and local governments. The company accepts interest-bearing and non-interest-bearing demand deposit accounts, money market deposit accounts, savings accounts, certificates of deposit, health savings accounts, and individual retirement accounts. Its loan products include commercial non-real estate loans, including commercial and agricultural loans; commercial and consumer real estate loans; residential real estate loans; home equity loans; various consumer loans, such as credit cards, automobile, and other consumer loans; and public sector and IDA loans, as well as loans for the construction of commercial and residential properties. The company also provides business and consumer debit and credit cards; letters of credit, night depository services, safe deposit boxes, utility payment services, and automatic funds transfer; wealth management, trust, and estate services; non-deposit investment and insurance products; and telephone, mobile, and Internet banking services, as well as operates automated teller machines. The company was founded in 1891 and is headquartered in Blacksburg, Virginia.
|
LAZY
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
N/A
|
PNI
|
PIMCO New York Municipal Income Fund II
|
Financial Services
|
Asset Management
|
United States
|
75436568
|
USD
|
N/A
|
PIMCO New York Municipal Income Fund II is a closed-ended fixed income mutual fund launched and managed by Pacific Investment Management Company LLC. It invests in the fixed income markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in municipal bonds that pay interest that is exempt from federal, New York State, and New York City income tax. It also invests in New York variable rate notes, New York variable rate demand notes, and U.S. treasury bills. The fund employs proprietary analytical models to make its investments. PIMCO New York Municipal Income Fund II was formed on March 29, 2002 and is domiciled in the United States.
|
ESQ
|
Esquire Financial Holdings, Inc.
|
Financial Services
|
Banks - Regional
|
United States
|
719230016
|
USD
|
138
|
Esquire Financial Holdings, Inc. operates as the bank holding company for Esquire Bank, National Association that provides commercial banking products and services to legal and small businesses, and commercial and retail customers in the United States. The company offers checking, savings, money market, and time deposits, as well as certificates of deposit. It also provides commercial loans, such as short-term financing for inventory, receivables, the purchase of supplies, or other operating needs arising during the normal course of business, as well as loans to its qualified ISO customers; commercial lines of credit; consumer loans consisting of post-settlement consumer and structured settlement loans to plaintiffs and claimants, as well as loans to individuals for debt consolidation, medical expenses, living expenses, payment of outstanding bills, and other consumer needs; and real estate loans, such as multifamily, 1-4 family residential, commercial real estate, and construction loans, as well as merchant services, including portfolio acquisition loan, agent residual acquisition loan, working capital line of credit, and merchant term loan. In addition, it offers cash management, cash sweep, online and mobile banking, and individual retirement accounts. Further, it provides payment processing, ACH and administrative services, and law firm banking solutions. Esquire Financial Holdings, Inc. was founded in 2006 and is headquartered in Jericho, New York.
|
QGRO
|
American Century U.S. Quality Growth ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
Under normal market conditions, the fund invests at least 80% of its assets, exclusive of collateral held from securities lending, in the component securities of the underlying index. The index is designed to select securities of large- and mid-capitalization U.S. companies with attractive growth and quality fundamentals.
|
BTT
|
Blackrock Municipal 2030 Target Term Trust
|
Financial Services
|
Asset Management
|
United States
|
1387037696
|
USD
|
N/A
|
Blackrock Municipal 2030 Target Term Trust is a closed end fixed income mutual fund launched by BlackRock, Inc. The fund is managed by by BlackRock Advisors, LLC. It invests in fixed income markets. The fund invests primarily in investment grade municipal bonds that are exempt from regular federal income tax. It was formerly known as BlackRock Municipal Target Term Trust. Blackrock Municipal 2030 Target Term Trust was formed on August 30, 2012 and is domiciled in the United States.
|
PLPC
|
Preformed Line Products Company
|
Industrials
|
Electrical Equipment & Parts
|
United States
|
687538752
|
USD
|
3401
|
Preformed Line Products Company, together with its subsidiaries, designs and manufactures products and systems that are used in the construction and maintenance of overhead, ground-mounted, and underground networks for the energy, telecommunication, cable, data communication, and other industries. The company offers optical ground wire products to support, protect, terminate, and splice transmission and distribution lines, as well as bolted, welded, and compressed connectors for substations; all dielectric self-supporting fiber optic cables to monitor and control power networks; and string hardware products, polymer insulators, wildlife protection, substation fittings, and motion control devices. It also provides rugged outside plant closures to protect and support wireline and wireless networks, such as fiber optic cable or copper cable from moisture, environmental hazards, and other contaminants; and hardware assemblies, pole line hardware, plastic products, cable dynamics/vibration solutions, interior/exterior connectors, tools, and urethane solutions that are used by energy, renewable energy, communications, cable, and special industries. In addition, the company provides drone inspection services for utility assets, including transmission and distribution power lines, substations, generation facilities, and communications assets, as well as solar framing and electric vehicle offerings. It serves public and private energy utilities and communication companies, cable operators, government agencies, contractors and subcontractors, distributors, and value-added resellers in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company markets its products through a direct sales force, as well as through manufacturing representatives. Preformed Line Products Company was incorporated in 1947 and is headquartered in Mayfield Village, Ohio.
|
SYBX
|
Synlogic, Inc.
|
Healthcare
|
Biotechnology
|
United States
|
13614261
|
USD
|
1
|
Synlogic, Inc., a biopharmaceutical company, engages in the discovery and development of synthetic biotics to treat metabolic diseases in the United States. Its pipeline include SYNB1618 for the treatment of phenylketonuria; SYNB1353, an orally administered, non-systemically absorbed drug candidate, which is in Phase I clinical to treat homocystinuria; SYNB8802, an orally administered, non-systemically absorbed drug candidate for the treatment of enteric hyperoxaluria; and SYNB2081 to lower uric acid for the potential treatment of gout. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd and Hoffmann-La Roche Inc.; and Ginkgo Bioworks, Inc. Synlogic, Inc. is based in Winchester, Massachusetts.
|
EVGN
|
Evogene Ltd.
|
Healthcare
|
Biotechnology
|
Israel
|
7406109
|
USD
|
117
|
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally. The company focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through its computational predictive biology (CPB) platform. It operates through three segments: Agriculture, Human Health, and other Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms. The Industrial Applications segment focuses on the development and commercialization of improved castor bean seeds for industrial uses. The company also provides medical cannabis products. Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.
|
DFJ
|
WisdomTree Japan SmallCap Dividend Fund
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
Under normal circumstances, at least 95% of the fund's total assets (exclusive of collateral held from securities lending) will be invested in constituent securities of the index and investments that have economic characteristics that are substantially identical to the economic characteristics of such constituent securities. The index is a fundamentally weighted index that is comprised of dividend-paying small capitalization companies in Japan. The fund is non-diversified.
|
PNF
|
PIMCO New York Municipal Income Fund
|
Financial Services
|
Asset Management
|
United States
|
55076000
|
USD
|
N/A
|
PIMCO New York Municipal Income Fund is a closed ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. It is co-managed by Pacific Investment Management Company LLC. The fund invests in fixed income markets. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in municipal securities. The fund's investment portfolio includes investments in hospital, water and sewer, tobacco, state and local general obligations, education, lease, tax, and power sectors. PIMCO New York Municipal Income Fund was formed on June 29, 2001 and is domiciled in United States.
|
CTRM
|
Castor Maritime Inc.
|
Industrials
|
Marine Shipping
|
Cyprus
|
21063924
|
USD
|
N/A
|
Castor Maritime Inc. provides shipping services worldwide. The company operates through Dry Bulk Vessels and Containerships segments. It offers seaborne transportation services for dry bulk cargo; and commodities, such as iron ore, coal, soybeans, etc. As of December 31, 2023, the company owned and operated a fleet of 17 vessels primarily consisting of one Capesize, five Kamsarmax, two Handysize tanker vessels, and nine Panamax dry bulk vessels, as well as two 2,700 TEU containership vessels. Castor Maritime Inc. was incorporated in 2017 and is based in Limassol, Cyprus.
|
SLNO
|
Soleno Therapeutics, Inc.
|
Healthcare
|
Biotechnology
|
United States
|
3704692480
|
USD
|
92
|
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
|
ACEL
|
Accel Entertainment, Inc.
|
Consumer Cyclical
|
Gambling
|
United States
|
952068736
|
USD
|
1500
|
Accel Entertainment, Inc., together with its subsidiaries, operates as a distributed gaming and local entertainment operator in the United States. It engages in the installation, maintenance, and operation of gaming terminals; redemption devices that disburse winnings and contain automated teller machine (ATM) functionality; and other amusement devices in authorized non-casino locations, such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The company also designs and manufactures gaming terminals and related equipment, as well as offers turnkey and full-service gaming solutions to bars, restaurants, convenience stores, truck stops, and fraternal and veteran establishments. In addition, it operates casionos; and stand-alone ATMs in gaming and non-gaming locations, as well as amusement devices, including jukeboxes, dartboards, pool tables, and other entertainment related equipment. The company is headquartered in Burr Ridge, Illinois.
|
FNCL
|
Fidelity MSCI Financials Index ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Financials 25/50 Index, which represents the performance of the financial sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Financials 25/50 Index. The fund is non-diversified.
|
RDWR
|
Radware Ltd.
|
Technology
|
Software - Infrastructure
|
Israel
|
989899968
|
USD
|
1137
|
Radware Ltd., together with its subsidiaries, develops, manufactures, and markets cyber security and application delivery solutions for cloud, on-premises, and software defined data centers worldwide. The company operates in two segments, Radware's Core Business and The Hawks' Business. It offers cloud application protection service, cloud WAF, bot manager, API protection, web DDoS protection, client-side protection, threat intelligence, Kubernetes WAAP, and alteon integrated WAF; cloud DDoS protection service, defencepro X, cyber controller, firewall as-a-service; alteon, linkproof NG, SSL inspection. The company also offers healthcare, education, open banking, and financial services. It sells its products primarily to independent distributors, including value added resellers, original equipment manufacturers, and system integrators. The company was founded in 1996 and is headquartered in Tel Aviv, Israel.
|
HIO
|
Western Asset High Income Opportunity Fund Inc.
|
Financial Services
|
Asset Management
|
United States
|
359474976
|
USD
|
N/A
|
Western Asset High Income Opportunity Fund Inc. is a closed ended fixed-income mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. It is co-managed by Western Asset Management Company and Western Asset Management Company Limited. The fund invests in the fixed income markets of the United States. It seeks to invest in high-yielding corporate debt obligations. The fund seeks to maintain an average duration of around four years with an average credit quality of B. It benchmarks the performance of its portfolio against the Barclays Capital U.S. Corporate High Yield 2% Issuer Cap Index. The fund was formerly known as High Income Opportunity Fund. Western Asset High Income Opportunity Fund Inc. was formed on November 16, 1993 and is domiciled in the United States.
|
OFLX
|
Omega Flex, Inc.
|
Industrials
|
Specialty Industrial Machinery
|
United States
|
317467808
|
USD
|
175
|
Omega Flex, Inc. manufactures and sells flexible metal hoses, fittings, and accessories in the United States, Canada, and internationally. It offers flexible gas piping for use in residential and commercial buildings; fittings; containment pining; and corrugated copper tubing for use in hospitals, ambulatory care centers, dental, physician and veterinary clinics, laboratories, and other facilities. The company sells its products under the TracPipe CSST, CounterStrike CSST, AutoFlare, DoubleTrac, DEF-Trac, and MediTrac brand names. It serves various markets, including construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. The company sells its products through independent sales representatives, distributors, wholesalers, original equipment manufacturers, and direct sales, as well as through its website. The company was formerly known as Tofle America, Inc. and changed its name to Omega Flex, Inc. in 1996. Omega Flex, Inc. was incorporated in 1975 and is based in Exton, Pennsylvania.
|
GAIA
|
Gaia, Inc.
|
Communication Services
|
Entertainment
|
United States
|
115334240
|
USD
|
104
|
Gaia, Inc. operates a digital video subscription service and online community for underserved member base in the United States, Canada, Australia, and internationally. It has a digital content library with various titles in Spanish, German, and French languages available to its subscribers on internet connected devices. The company's network comprises Seeking Truth that provides topics that include ancient wisdom and metaphysics; Transformation channel that offers content in the areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel focuses on food and nutrition, holistic healing, alternative and integrative medicines, and longevity; and Yoga channel, which provides access to streaming yoga, Eastern arts, and other movement based classes. The company was formerly known as Gaiam, Inc. and changed its name to Gaia, Inc. in July 2016. Gaia, Inc. was incorporated in 1988 and is headquartered in Louisville, Colorado.
|
ETB
|
Eaton Vance Tax-Managed Buy-Write Income Fund
|
Financial Services
|
Asset Management
|
United States
|
389508544
|
USD
|
N/A
|
Eaton Vance Tax-Managed Buy-Write Income Fund is a closed-ended equity mutual fund launched and managed by Eaton Vance Management. It is co-managed by Parametric Portfolio Associates LLC. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating across diversified sectors. The fund primarily invests in stocks of large-cap companies. It also writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio. The fund benchmarks the performance of its portfolio against the S&P 500 Index. Eaton Vance Tax-Managed Buy-Write Income Fund was formed on April 29, 2005 and is domiciled in the United States.
|
RIV
|
RiverNorth Opportunities Fund, Inc.
|
Financial Services
|
Asset Management
|
United States
|
245964048
|
USD
|
N/A
|
RiverNorth Opportunities Fund, Inc. is a close ended equity mutual fund co- launched and co- managed by ALPS Advisors, Inc. and RiverNorth Capital Management, LLC. It invests in the equity markets. The fund seeks to invest in stocks of companies operating across the diversified sectors. RiverNorth Opportunities Fund, Inc. was formed on December 24, 2015 and is domiciled in the United States.
|
SPTI
|
SPDR Portfolio Intermediate Term Treasury ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in securities that the Adviser determines have economic characteristics that are substantially identical to the economic characteristics of the securities that comprise the index. The index is designed to measure the performance of intermediate term (3-10 years) public obligations of the U.S. Treasury.
|
EVG
|
Eaton Vance Short Duration Diversified Income Fund
|
Financial Services
|
Asset Management
|
United States
|
146042496
|
USD
|
N/A
|
Eaton Vance Short Duration Diversified Income Fund is a closed ended fixed income mutual fund launched and managed by Eaton Vance Management. The fund invests in fixed income markets of the United States. It primarily invests in senior, secured floating-rate loans, bank deposits denominated in foreign currencies, debt obligations of foreign governmental and corporate issuers, and mortgage-backed securities. The fund invests in fixed income securities operating across diversified sectors. It invests in fixed income securities with an average duration of 1.76 years and an average credit quality of least BBB. The fund benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index. It was formerly known as Eaton Vance Low Duration Diversified Income Fund. Eaton Vance Short Duration Diversified Income Fund was formed on February 28, 2005 and is domiciled in the United States.
|
NRT
|
North European Oil Royalty Trust
|
Energy
|
Oil & Gas E&P
|
United States
|
41725256
|
USD
|
2
|
North European Oil Royalty Trust, a grantor trust, holds overriding royalty rights covering gas and oil production in various concessions or leases in the Federal Republic of Germany. The company also has rights under contracts with German exploration and development subsidiaries of ExxonMobil Corp. and the Royal Dutch/Shell Group of Companies. In addition, it holds royalties for the sale of gas well gas, oil well gas, crude oil, condensate, and sulfur. North European Oil Royalty Trust was founded in 1975 and is based in Keene, New Hampshire.
|
VWOB
|
Vanguard Emerging Markets Government Bond Index Fund
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The manager employs an indexing investment approach designed to track the performance of index. All of the fund's investments will be selected through the sampling process, and under normal circumstances at least 80% of the fund's assets will be invested in bonds included in the index. It is non-diversified.
|
SONN
|
Sonnet BioTherapeutics Holdings, Inc.
|
Healthcare
|
Biotechnology
|
United States
|
4200009
|
USD
|
13
|
Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 to treat chemotherapy-induced peripheral neuropathy (CIPN), and diabetic peripheral neuropathy; SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer; SON-1411, a bifunctional combination of human interleukin 18 (IL-18) inhibitor binding protein and single-chain human IL-12 (IL-12) for solid tumor cancers; and SON-1400, a monofunctional fusion protein comprising the IL-18 binding protein resistant domain linked to the FHAB. It has a license agreement with New Life Therapeutics Pte, Ltd. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.
|
NBSE
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
CVM
|
CEL-SCI Corporation
|
Healthcare
|
Biotechnology
|
United States
|
24942776
|
USD
|
N/A
|
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development to treat cancer and other diseases by using the immune system in the United States. The company's lead immunotherapy is Multikine, which has completed Phase III clinical trials for the potential treatment of certain head and neck cancers. It is also developing Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer, as well as to potentially treat rheumatoid arthritis. In addition, the company's LEAP product candidates include CEL-2000; CEL-4000; and CEL-5000 that are in preclinical trials for potential rheumatoid arthritis therapeutic treatments. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.
|
CYD
|
China Yuchai International Limited
|
Consumer Cyclical
|
Auto Manufacturers
|
Singapore
|
581158464
|
USD
|
N/A
|
China Yuchai International Limited, through its subsidiaries, manufactures, assembles, and sells diesel and natural gas engines for trucks, buses, pickups, construction and agricultural equipment, and marine and power generation applications in the People's Republic of China and internationally. It operates through two segments, Yuchai and HLGE. The Yuchai segment manufactures on- and off-road powertrain solutions and applications. The HLGE is engaged in hospitality and property development activities. The company provides diesel engines comprising 4- and 6-cylinder diesel engines, high horsepower marine diesel engines, and power generator engines; natural gas engines, hydrogen combustion engines, methanol combustion engines, diesel power generators, diesel engine parts, and remanufacturing services; as well as plug in hybrid engines, range extenders, power generation powertrains, hybrid powertrains, integrated electric drive axle powertrain, and fuel cell systems. It also offers repair, maintenance, and retrofitting services. It distributes its engines directly to auto original equipment manufacturers, agents, and retailers. The company was founded in 1951 and is based in Singapore.
|
BBN
|
BlackRock Taxable Municipal Bond Trust
|
Financial Services
|
Asset Management
|
United States
|
991769600
|
USD
|
N/A
|
BlackRock Taxable Municipal Bond Trust is a closed-ended fixed income mutual fund launched by BlackRock, Inc. It is managed by BlackRock Advisors, LLC. The fund invests in the fixed income markets of the United States. It primarily invests in taxable municipal securities, which include Build America Bonds. The fund also invests in tax-exempt securities, U.S. treasury securities, obligations of the U.S. government, its agencies and instrumentalities, and corporate bonds. It was formerly known as BlackRock Build America Bond Trust. BlackRock Taxable Municipal Bond Trust was formed on August 27, 2010 and is domiciled in the United States.
|
PWFL
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
OVID
|
Ovid Therapeutics Inc.
|
Healthcare
|
Biotechnology
|
United States
|
24655916
|
USD
|
23
|
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
|
VEL
|
Velocity Financial, Inc.
|
Financial Services
|
Mortgage Finance
|
United States
|
648626368
|
USD
|
309
|
Velocity Financial, Inc. operates as a real estate finance company in the United States. It originates, securitizes, and manages a portfolio of loans, which are secured by real estate, including investor 1-4 unit residential rental properties; residential apartments combined with office or retail space; and loans for multi-family, mixed use, and commercial properties. The company also provides warehouse and other properties. It offers its products through a network of independent mortgage brokers and direct borrower relationships. The company was founded in 2004 and is headquartered in Westlake Village, California
|
OESX
|
Orion Energy Systems, Inc.
|
Consumer Cyclical
|
Furnishings, Fixtures & Appliances
|
United States
|
24051738
|
USD
|
260
|
Orion Energy Systems, Inc., together with its subsidiaries, researches, designs, develops, manufactures, markets, sells, installs, and implements energy management systems for commercial office and retail, area lighting, industrial applications, and government in North America and Germany. It operates in three segments: Lighting, Maintenance, and Electric Vehicle (EV). The company offers light emitting diode (LED) lighting products; construction and engineering services for commercial lighting and energy management system; lighting and electrical system maintenance, repair, and replacement services; and EV charging station and installation solutions. It also provides LED high bay fixtures and LED troffer retrofits; smart lighting controls, a wireless Internet of Things enabled control solution that provides lighting control options and data intelligence capabilities for building managers; and various LED fixtures for lighting and energy management needs comprising fixtures for agribusinesses, parking lots, roadways, retail, mezzanine, outdoor applications, and private label resale. In addition, the company offers lighting-related energy management services, such as site assessment, site field verification, utility incentive and government subsidy management, engineering design, project management, facility design commissioning, and recycling. It serves customers directly and through independent sales agencies and distributors, national account end-users, federal and state government facilities, regional account end-users, electrical distributors, electrical contractors, and energy service companies. Orion Energy Systems, Inc. was incorporated in 1996 and is headquartered in Manitowoc, Wisconsin.
|
ETO
|
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund
|
Financial Services
|
Asset Management
|
United States
|
398394688
|
USD
|
N/A
|
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund is a closed ended equity mutual fund launched and managed by Eaton Vance Management. It invests in public equity markets across the globe. The fund seeks to invest in the stocks of companies operating across diversified sectors. It primarily invests in dividend paying value stocks of companies. The fund employs fundamental analysis to create its portfolio. It benchmarks the performance of its portfolio against the MSCI World Index. Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund was formed on April 30, 2004 and is domiciled in the United States.
|
CNFR
|
Conifer Holdings, Inc.
|
Financial Services
|
Insurance - Property & Casualty
|
United States
|
8409358
|
USD
|
9
|
Conifer Holdings, Inc., an insurance holding company, engages in the homeowners insurance and dwelling fire insurance business to individuals in the United States. The company was incorporated in 2009 and is headquartered in Troy, Michigan.
|
HEWJ
|
iShares Currency Hedged MSCI Japan ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund generally will invest at least 80% of its assets in the component securities and other instruments of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is designed to measure the performance of the large- and mid-capitalization segments of the Japanese equity market with the currency risk inherent in the securities included in the underlying index hedged to the U.S. dollar on a monthly basis.
|
TOTL
|
SPDR DoubleLine Total Return Tactical ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
Under normal circumstances, the Sub-Adviser will invest at least 80% of the fund's net assets in a portfolio of fixed income securities of any credit quality. The fund may invest up to 25% of its net assets in corporate high yield securities (commonly known as "junk bonds"). It may invest up to 15% of its net assets in securities denominated in foreign currencies, and may invest beyond this limit in U.S. dollar-denominated securities of foreign issuers.
|
WSBF
|
Waterstone Financial, Inc.
|
Financial Services
|
Banks - Regional
|
United States
|
235807200
|
USD
|
600
|
Waterstone Financial, Inc. operates as a bank holding company for WaterStone Bank SSB that provides various financial services to customers in southeastern Wisconsin, the United States. It operates in two segments, Community Banking and Mortgage Banking. The Community Banking segment offers consumer and business banking products and services, such as deposit and transactional solutions, such as checking, credit, debit and pre-paid cards, online banking and bill pay, and money transfer services; investable funds solutions, such as savings, money market deposits, individual retirement accounts, and certificates of deposit; residential mortgages, home equity loans and lines of credit, personal and installment loans, real estate financing, business loans, and business lines of credit; and fixed and variable annuities, insurance products, and trust and investment management accounts. It also provides transaction deposits, interest bearing transaction accounts, demand deposits, non-interest-bearing demand accounts, and time deposits; secured and unsecured lines; commercial real estate construction loans; term loans for working capital, inventory, and general corporate use; and personal term loans and investment services. The Mortgage Banking segment offers residential mortgage loans for the purpose of sale in the secondary market. It also invests in a portfolio of securities include mortgage-backed securities, government-sponsored and private-label enterprise bonds, collateralized mortgage obligations, municipal obligations, and other debt securities. The company was formerly known as Wauwatosa Holdings, Inc. and changed its name to Waterstone Financial, Inc. in August 2008. The company was founded in 1921 and is based in Wauwatosa, Wisconsin.
|
PINE
|
Alpine Income Property Trust, Inc.
|
Real Estate
|
REIT - Retail
|
United States
|
255598016
|
USD
|
N/A
|
Alpine Income Property Trust, Inc. (the Company or PINE) is a real estate investment trust (REIT) that owns and operates a high-quality portfolio of commercial net lease properties. The terms us, we, our, and the Company as used in this report refer to Alpine Income Property Trust, Inc. The Company is a Maryland corporation that was formed on August 19, 2019. The Company has no employees and is externally managed by Alpine Income Property Manager, LLC, a Delaware limited liability company and a wholly owned subsidiary of CTO Realty Growth, Inc. (our Manager). CTO Realty Growth, Inc. (NYSE: CTO) is a Maryland corporation that is a publicly traded REIT and the sole member of our Manager (CTO).
|
BWX
|
SPDR Bloomberg International Treasury Bond ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in securities that the Adviser determines have economic characteristics that are substantially identical to the economic characteristics of the securities that comprise the index. The index is designed to track the fixed-rate local currency sovereign debt of investment grade countries outside the United States. It is non-diversified.
|
PYN
|
PIMCO New York Municipal Income Fund III
|
Financial Services
|
Asset Management
|
United States
|
30688980
|
USD
|
N/A
|
PIMCO New York Municipal Income Fund III is a close ended fixed income mutual fund launched and managed by Allianz Global Investors Fund Management LLC. The fund is co-managed by Pacific Investment Management Co LLC. It invests in fixed income markets. The fund seeks to invest in stocks of companies operating across diversified sectors. It invests in a portfolio of New York municipal bonds, and other municipal bonds and notes; New York variable rate notes and other variable rate notes; New York variable rate demand notes and other variable rate demand notes; U.S. treasury bills; and call options written and put options written. PIMCO New York Municipal Income Fund III was on October 31, 2002 and is domiciled in United States.
|
BYSI
|
BeyondSpring Inc.
|
Healthcare
|
Biotechnology
|
United States
|
66147040
|
USD
|
40
|
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. It operates through two segments: Plinabulin pipeline and TPD platform. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia. It is also developing Plinabulin in combination with docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy and radiation; nivolumab, a PD-1 antibody that is has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.
|
EFT
|
Eaton Vance Floating-Rate Income Trust
|
Financial Services
|
Asset Management
|
United States
|
318661056
|
USD
|
N/A
|
Eaton Vance Floating-Rate Income Trust is a closed-ended fixed income mutual fund launched and managed by Eaton Vance Management. The fund invests in fixed income markets of the United States. It invests in fixed income securities operating across diversified sectors. The fund primarily invests in senior, secured floating rate loans. It benchmarks the performance of its portfolio against the S&P/LSTA Leveraged Loan Index. Eaton Vance Floating-Rate Income Trust was formed on June 29, 2004 and is domiciled in the United States.
|
CSTL
|
Castle Biosciences, Inc.
|
Healthcare
|
Diagnostics & Research
|
United States
|
603724544
|
USD
|
761
|
Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), uveal melanoma, and mental health conditions. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the risk of metastasis for patients with uveal melanoma; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a risk stratification spatial-omics test to predict future development of progression of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma; and IDgenetix, a pharmacogenomic test that helps guide optimal drug treatment for patients diagnosed with major depressive disorder, schizophrenia, bipolar disorder, anxiety disorders, social phobia, obsessive-compulsive personality disorder, post-traumatic stress disorder, and attention deficit hyperactivity disorder. The company offers its products to skin cancer and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.
|
FGD
|
First Trust Dow Jones Global Select Dividend Index Fund
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is an indicated annual dividend yield weighted index of 100 stocks selected from the developed-market portion of the Dow Jones World Index SM.
|
EDIV
|
SPDR S&P Emerging Markets Dividend ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index and in depositary receipts based on securities comprising the index. The index is designed to measure the performance of 100 high-yielding emerging market common stocks.
|
XLG
|
Invesco S&P 500 Top 50 ETF
|
N/A
|
N/A
|
N/A
|
N/A
|
USD
|
N/A
|
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The index provider compiles, maintains and calculates the underlying index, which consists of the 50 largest companies in the S&P 500® Index based on float-adjusted market capitalization. The underlying index's components are weighted by float-adjusted market capitalization. The fund is non-diversified.
|
SPTM
|
SPDR Portfolio S&P 1500 Composite Stock Market ETF
|
N/A
|
N/A
|
N/A
|
6348370432
|
USD
|
N/A
|
Under normal market conditions, the fund generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index is designed to measure the performance of the large-, mid-, and small-capitalization segments of the U.S. equity market. The index consists of those stocks included in the S&P 500 Index, the S&P MidCap 400 Index, and the S&P SmallCap 600 Index.
|
MASI
|
Masimo Corporation
|
Healthcare
|
Medical Devices
|
United States
|
8847723520
|
USD
|
3600
|
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arterial oxygen saturation, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, NomoLine capnography and gas monitoring, and regional oximetry. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, SafetyNet, Replica, Iris, MyView, UniView, Uniview: 60, Masimo Sleep, Centroid, and Bridg; and nasal high-flow respiratory support therapy, neuromodulation technology, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and home wellness products through e-commerce internet sites, such as masimopersonalhealth.com, amazon.com, and shopify.com. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
|
WEA
|
Western Asset Premier Bond Fund
|
Financial Services
|
Asset Management
|
United States
|
129928592
|
USD
|
N/A
|
Western Asset Premier Bond Fund is a closed-ended fixed income mutual fund launched and managed by Western Asset Management Company. The fund is co-managed by Western Asset Management Company Limited, Western Asset Management Company Pte. Ltd., and Western Asset Management Company Ltd. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade bonds, including corporate bonds, U.S. government and agency securities, and mortgage related securities. It seeks to maintain an average duration of around two to three years with an average credit quality of BBB. The fund benchmarks the performance of its portfolio against the Barclays Capital U.S. Corporate High Yield Index and the Barclays Capital U.S. Credit Index. Western Asset Premier Bond Fund was formed on March 28, 2002 and is domiciled in the United States.
|
MRBK
|
Meridian Corporation
|
Financial Services
|
Banks - Regional
|
United States
|
159913040
|
USD
|
322
|
Meridian Corporation operates as the bank holding company for Meridian Bank that provides commercial banking products and services in Pennsylvania, New Jersey, Delaware, Maryland, and Florida. It provides various deposit products, such as demand non-interest and interest bearing, savings, and money market accounts, as well as time deposits. The company also offers commercial and industrial loans, including business lines of credit, term loans, small business lending, lease financing, shared national credits, and other financing; commercial real estate, and land development and construction loans for residential and commercial projects; and consumer and home equity lending, private banking, merchant, and title insurance and land settlement services. In addition, it operates and originates mortgage loans for 1-4 family dwellings; and offers real estate holding, investment advisory, and equipment leasing services, as well as provides financial planning and wealth management services. The company was founded in 2004 and is headquartered in Malvern, Pennsylvania.
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.